A Double Stranded Dna Plasmid Vaccine Construct Encoding Ubiquitin-human Telomerase Reverse Transcriptase (htert) Fusion Protein
A Double Stranded Dna Plasmid Vaccine Construct Encoding Ubiquitin-human Telomerase Reverse Transcriptase (htert) Fusion Protein Uses, Dosage, Side Effects, Food Interaction and all others data.
A Double Stranded Dna Plasmid Vaccine Construct Encoding Ubiquitin-human Telomerase Reverse Transcriptase (htert) Fusion Protein is under investigation in clinical trial NCT03265717 (DNA Plasmid Encoding a Modified Human Telomerase Reverse Transcriptase (Htert), Invac-1 in Chronic Lymphocytic Leukemia).
| Trade Name | A Double Stranded Dna Plasmid Vaccine Construct Encoding Ubiquitin-human Telomerase Reverse Transcriptase (htert) Fusion Protein |
| Generic | INVAC-1 |
| INVAC-1 Other Names | Human telomerase reverse transcriptase (htert) dna vaccine invac-1, Invac-1, a double stranded dna plasmid vaccine construct encoding ubiquitin-human telomerase reverse transcriptase (htert) fusion protein |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here A Double Stranded Dna Plasmid Vaccine Construct Encoding Ubiquitin-human Telomerase Reverse Transcriptase (htert) Fusion Protein
